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Only few smaller studies have examined if impaired kidney function increases the risk of
acute kidney injury in patients with acute pyelonephritis. Therefore, we estimated 30-day
risk of acute kidney injury by preadmission kidney function in patients with acute pyelone-
phritis. Furthermore, we examined if impaired kidney function was a risk factor for develop-
ment of acute kidney injury in pyelonephritis patients.
Methods
This cohort study included patients with a first-time hospitalization with pyelonephritis from
2000 to 2017. Preadmission kidney function (estimated glomerular filtration rate (eGFR)
<30, 30–44, 45–59, 60–89, and�90 ml/min/1.73 m2) and acute kidney injury within 30 days
after admission were assessed using laboratory data on serum creatinine. The absolute 30-
days risk of acute kidney injury was assessed treating death as a competing risk. The impact
of eGFR on the odds of acute kidney injury was compared by odds ratios (ORs) with 95%
confidence intervals estimated using logistic regression adjusted for potential confounding
factors.
Results
Among 8,760 patients with available data on preadmission kidney function, 25.8% had a
preadmission eGFR <60. The 30-day risk of acute kidney injury was 16% among patients
with preadmission eGFR�90 and increased to 22%, 33%, 42%, and 47% for patients with
preadmission eGFR of 60–89, 45–59, 30–44, and <30 respectively. Compared with
eGFR�90, the adjusted ORs for the subgroups with eGFR 60–89, 45–59, 30–45, and <30
were 0.95, 1.32, 1.78, and 2.19 respectively.
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Conclusion
Acute kidney injury is a common complication in patients hospitalized with acute pyelone-
phritis. Preadmission impaired kidney function is a strong risk factor for development of
acute kidney injury in pyelonephritis patients and more attention should be raised in preven-
tion of pyelonephritis in patients with a low kidney function.
Introduction
Urinary tract infection is a common bacterial infection mainly affecting the lower urinary
tract, but the bacteria occasionally ascend and cause upper urinary tract infection, i.e. pyelone-
phritis [1]. The incidence rate of hospitalized pyelonephritis ranges from 1–2 per 10,000 per-
son-years in men to 3–4 per 10,000 person-years in women. The highest incidences are found
among infants, young women, and the elderly [2]. Acute kidney injury (AKI) is a potential
serious complication to acute pyelonephritis and it is broadly defined by an abrupt decrease in
kidney function measured by increasing serum creatinine or lowered urine output [3]. Data
on AKI in patients with pyelonephritis are limited. While one in five hospitalized adults may
develop AKI [4], a smaller Korean cohort study of 403 patients reported that up to 62.8% of
adults hospitalized with acute pyelonephritis developed AKI [5]. Another Taiwanese cohort
study of 790 patients reported a 2.63-fold (95% CI 1.53–4.56) increase in the odds of AKI in
patients with pyelonephritis compared with patients admitted with lower urinary tract infec-
tion [6]. In that study, patients with high age, low baseline estimated glomerular filtration rate
(eGFR), and diabetes had the highest odds of AKI [6].
Many previous observational cohort studies examining AKI lacked laboratory information
on preadmission serum creatinine [7, 8]. Instead, they identified AKI from diagnostic code,
used admission creatinine as baseline value or estimated baseline of creatinine assuming eGFR
to be 75 ml/min/1.73m2 [9, 10]. Even though AKI and chronic kidney disease are associated
conditions [11–13], only few studies with a small number of patients have examined if
impaired kidney function increases the risk of AKI in patients with pyelonephritis [5, 6]. To
address the limitation of missing preadmission laboratory information on serum creatinine in
the current literature, we took advantage of the nationwide Danish population-based health
registries and the potential for identifying preadmission kidney function and AKI from creati-
nine measurements from laboratory databases. Accordingly, we conducted a large nationwide
population-based cohort study to estimate the 30-day risk of AKI by preadmission kidney
function. Furthermore, we examined if impaired preadmission kidney function is a risk factor
for development of AKI among patients hospitalized with acute pyelonephritis. Such knowl-
edge could direct more attention to prevention of pyelonephritis and associated AKI in those
with reduced kidney function to prevent further decline of kidney function [11].
Materials and methods
Study design
This historical cohort study conducted in Denmark (population ~ 5.8 million), which has a
large amount of routinely collected population-based medical data covering all hospital admis-
sions, hospital diagnoses, medical prescriptions, and any deaths [14]. All Danish citizens have
a unique 10-digit civil registration number, which is assigned at birth or immigration, includ-
ing information on sex and date of birth [15–17]. This number facilitates linkage of
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individual-level data between Danish databases including laboratory databases, The Danish
Civil Registration System, The Danish National Patient Registry, and The Danish National
Prescription Registry [14–16, 18–21]. The Danish health care system is tax-funded and there-
fore all Danish citizens have free access to medical care at public hospitals. Private hospitals
account for less than 1% of all hospital admissions and all acute care, including hospital treat-
ment of pyelonephritis, is provided by public hospitals [14].
Data were accessed through remote access to secure servers at the Danish Health Data
Authority after approval by the Danish Health Data Authority (FSEID-00003631) and the
Danish Data Protection Agency through registration at Aarhus University (record number
2016-051-000001/812). According to Danish legislation, no ethical approval was required. The
data were linked and pseudonymized (i.e., the 10-digit civil registration number was removed)
by Danish Health Data Authority before we had data access.
Study population with pyelonephritis
We included patients 18 or older with a first-time inpatient primary or secondary diagnosis of
acute pyelonephritis from 1 January 2000 to 31 December 2017 coded according to the Inter-
national Classification of Diseases 10th version (ICD-10) recorded in The Danish National
Patient Registry [20]. To allow linkage and complete follow-up, we required a valid Danish
10-digit civil registration number including information on sex and date of birth [14–17]. We
excluded patients with any ICD-10 diagnosis of chronic tubulo-interstitial nephritis prior to
index date (i.e. date of hospital admission) to avoid capture of recurrent episodes of pyelone-
phritis. We additionally excluded patients with missing information on vital status in the 30
days after admission to allow complete follow-up and patients with preadmission chronic dial-
ysis. Patients with muscular dystrophy, paraplegia or tetraplegia were excluded because the
muscle atrophy causes low preadmission creatinine and thereby falsely elevated preadmission
eGFR, which may bias our findings. In a clinical setting creatinine also would not be used to
assess kidney function in these patients [22]. Finally, we excluded patients without any serum
creatinine (sCr) measurements within 30 days after hospital admission. These patients are
most probably admitted at hospitals not covered by the laboratory databases yet, because we
assume that all patients admitted with acute pyelonephritis will have at least one creatinine
measurement at admission [23]. Patients lacking outpatient creatinine measurements prior to
index date were excluded in the main analyses only including complete cases, but included in
the sensitivity analyses. All ICD-10 diagnosis codes used for inclusion and exclusion are listed
in S1 Table.
Variables
Exposure. Preadmission eGFR was calculated from the Chronic Kidney Disease Epidemi-
ology Collaboration creatinine equation (CKD-EPI equation) using the most recent outpatient
of routine sCr measurement within one year to seven days before the date of pyelonephritis
hospitalization [24, 25]. Measurements in the seven days preceding admission were not
included to avoid preadmission eGFR being affected of acute illness due to pyelonephritis. Age
and sex were used for calculation assuming that all patients were Caucasian, which is a reason-
able assumption to make of the Danish population. eGFR was further categorized into <30,
30–44, 45–59, 60–89, and�90 corresponding to the eGFR categorization of chronic kidney
disease from Kidney Disease Improving Global Outcomes (KDIGO) [26]. Data on sCr were
retrieved from the Register of Laboratory Results for Research [21], which contains collected
results from inpatients, outpatients, and visitors at the general practitioners from all regions of
Denmark except from the Central Denmark region from where we retrieved information from
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the regional clinical laboratory information system (LABKA) database [18]. The laboratory
databases are increasingly complete throughout the study period, but unfortunately, not all
regions of Denmark are covered throughout the study period.
Outcome. We followed sCr in all patients from the day at admission and up to 30 days to
assess occurrence of AKI (yes/no). According to the guidelines from KDIGO, AKI was defined as
an at least 1.5 times relative increase from preadmission sCr, a relative increase of at least 1.5 in
sCr within a period of seven days, or an absolute increase in sCr of at least 26.5 μmol/l within a
period of 48 hours [3]. Preadmission sCr was defined as the most recent sCr outpatient of rou-
tine measurement within one year to seven days before the date of pyelonephritis hospitalization
[24, 27]. We did not include urine output in our outcome definition as this information was not
available which is generally accepted in AKI-research in a non-intensive-care setting [28].
Covariates. Potential confounders were identified through existing knowledge and litera-
ture on causal mechanisms and afterwards directed acyclic graphs were constructed [5–7, 29–
35]. We therefore collected information on the following potential confounders: age, sex, dia-
betes, hypertension, malformation of the urinary tract, and heart failure. Information on age
and sex were retrieved from the civil registration number through The Danish Civil Registra-
tion System [15]. Information on the other variables were found through ICD-8 and ICD-10
diagnosis codes from The Danish National Patient Registry covering all registered diagnosis
codes since 1977 [20, 36]. We also used The Danish National Prescription Registry to identify
patients treated for diabetes but without any diabetes-related visits at the hospital [19]. We
included information on all diagnosis codes since 1977 and all prescriptions since 1994. ICD-
8, ICD-10, and ATC codes are listed in Supporting information.
Statistical analyses
All analyses were performed with Stata software version 14. In Table 1, we described baseline
characteristics of patients separated into the five different eGFR categories and patients with
missing preadmission baseline creatinine. Sex and comorbidity were described by counts and
percentages and age was presented as medians with interquartile ranges.
Main analyses were using only complete cases, i.e. excluding all patients with missing infor-
mation on preadmission kidney function. All analyses were conducted with the patients
Table 1. Baseline characteristics of the different eGFR categories and the patients with missing preadmission eGFR (column percentages).
Characteristics eGFR < 30 eGFR 30–44 eGFR 45–59 eGFR 60–89 eGFR� 90 Total Missing preadmission sCr
N 452 (100.00) 734 (100.0) 1,076 (100.0) 3,249 (100.0) 3,249 (100.0) 8,760 (100.0) 7,287 (100.0)
Sex, n (%)
Male 213 (47.1) 331 (45.1) 445 (41.4) 1,291 (39.7) 708 (21.8) 2,988 (34.1) 1,414 (19.4)
Female 239 (52.9) 403 (54.9) 631 (58.6) 1,958 (60.3) 2,541 (78.2) 5,772 (65.9) 5,873 (80.6)
Age, median (IQR) 79 (70–85) 79 (71–85) 76 (68–89) 69 (59–77) 43 (29–57) 65 (46–76) 38 (25–58)
Comorbidity, n (%)
Diabetes 135 (29.9) 224 (30.5) 283 (26.3) 590 (18.2) 508 (15.6) 1,740 (19.9) 380 (5.2)
Malformation of the urinary tract 13 (2.9) 14 (1.9) 29 (2.7) 39 (1.2) 37 (1.1) 132 (1.5) 81 (1.1)
Hypertension 259 (57.3) 436 (59.4) 542 (50.4) 1,165 (35.9) 490 (15.1) 2,892 (33.0) 616 (8.5)
Heart failure 103 (22.8) 154 (21.0) 154 (14.3) 224 (6.9) 55 (1.7) 690 (7.9) 160 (2.2)
Obstructive nephropathy 100 (22.1) 134 (18.3) 156 (14.5) 245 (7.5) 156 (4.8) 791 (9.0) -
Nephrolithiasis 41 (9.1) 57 (7.8) 117 (10.9) 301 (9.3) 303 (9.3) 819 (9.3) -
Imputed preadmission eGFR, median (IQR) - - - - - - 102 (82–119)
Abbreviations: eGFR, estimated glomerular filtration rate; sCR, serum creatinine; IQR, Interquartile range.
https://doi.org/10.1371/journal.pone.0247687.t001
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separated into the different exposure groups with a reference group of patients with preadmis-
sion eGFR�90 ml/min/1.73 m2. The patients were included from the date of pyelonephritis
hospitalization and followed for 30 days or until an event of AKI or death, whichever came
first. We estimated the absolute 30-day risk of AKI and generated a graph of the absolute
cumulative 30-day risk of AKI by preadmission kidney function [37]. Death was treated as a
competing risk [38]. In the primary analysis, we used logistic regression to determine the asso-
ciation between preadmission eGFR category and AKI within 30 days after pyelonephritis
admission. To account for potential confounding, we adjusted for the following covariates:
age, sex, hypertension, diabetes, malformation of the urinary tract, and heart failure.
To examine the association between eGFR on a continuous scale without categorization of
eGFR and AKI, we modelled a restricted cubic spline function adjusted for the same con-
founders as the aforementioned logistic regression [39]. The reference value was eGFR 90 ml/
min/1.73 m2 and the spline included five knots.
Sensitivity analyses. We included and imputed preadmission creatinine for the 7,287
patients with missing preadmission creatinine. We presumed that information on these
patients was missing at random because we believe that lacking preadmission creatinine pri-
marily depends on measured variables like age and comorbidity and that is it not directly
related to preadmission creatinine level. Imputations were made using information on: age,
sex, Charlson Comorbidity Index, congestive heart failure, chronic kidney disease, hyperten-
sion, diabetes, cerebrovascular disease, peripheral vascular disease, former recorded usage of
catheter a demeure, chronic liver disease, acute dialysis at any time before index, the lowest
creatinine measurements in the 30 days after index, and acute dialyses in the 30 days after
index [40] (S1 Table). Preadmission creatinine was imputed 50 times and imputed values were
averaged for the adjusted logistic regression analysis [40, 41]. We also estimated the absolute
30-day risk of AKI including patients with imputed preadmission values of creatinine. For
another sensitivity analysis, we used logistic regression model to examine the association
between preadmission eGFR category and AKI within 7 days after admission.
To examine potential effect modification by sex, we conducted a logistic regression analysis
stratified by sex and a likelihood ratio test for interaction for the fully adjusted logistic regres-
sion with and without an interaction term between age and eGFR. All sensitivity analyses were
adjusted for the same covariates as the primary analysis.
We used logistic regression model to conduct a final sensitivity analysis including obstruc-
tive nephropathy as a covariate.
Results
Patient characteristics
We identified 34,406 adult patients hospitalized with acute pyelonephritis. After applying the
first four exclusion criteria, 33,190 patients remained (Fig 1). A total of 16,047 patients of the
remaining 33,190 patients were covered by the laboratory databases. Among those patients,
8,760 patients had a creatinine measurement one year to seven days before admission and
were included in the primary analysis of complete cases. Patients excluded from the primary
analyses because of missing preadmission creatinine were overall younger, more often female,
and less comorbid than those included in subsequent analyses (Table 1, last column). Among
patients with preadmission creatinine, there were more women than men with pyelonephritis
(65.9% vs. 34.1%). The median age was 65 years (IQR 46–76 years). The majority (74.2%) of
the patients included in the study had a preadmission eGFR� 60 ml/min/1.73 m2, 12.3% had
an eGFR between 45 and 59 ml/min/1.73 m2, 8.4% had an eGFR between 30 and 44 ml/min/
1.73 m2, and 5.2% had an eGFR below 30 ml/min/1.73 m2 (Table 1). Patients with a lower
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eGFR tended to be older and include more male patients. In total, 19.9% of all patients had dia-
betes, 1.5% had a malformation of the urinary tract, 33.0% had hypertension, and 7.9% had a
diagnosis of heart failure. The prevalence of comorbidity increased with lower eGFR (Table 1).
Acute kidney injury
Among the 8,760 patients with a preadmission creatinine, we observed 2,108 incident cases of
AKI during the follow-up period. The cumulative 30-day risk of AKI was 24% (95% CI: 23%;
Fig 1. Flowchart of patient inclusion and exclusions. �Patients not covered by the laboratory databases.
https://doi.org/10.1371/journal.pone.0247687.g001
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25%) for any cohort participant with pyelonephritis with a total of 64 competing death events.
The 30-day risk of AKI increased with lower preadmission eGFR (Fig 2). For patients with an
eGFR below 30 ml/min/1.73 m2, the AKI risk was 47% (95% CI: 42%; 51%), which is notable
higher than patients with an eGFR� 90 ml/min/1.73 m2 who had a 30-day AKI risk of 16% (95%
CI: 14%; 17%). This association persisted when adjusting for all included confounders (Fig 3).
In accordance with the ORs from the logistic regression, the ORs from restricted cubic
spline model increased with lower eGFR for preadmission eGFR below 90 ml/min/1.73 m2
(Fig 4). The cubic spline was U-shaped and ORs increased in patients with preadmission
eGFR above 90 ml/min/1.73 m2.
Sensitivity analyses. The findings were confirmed in the sensitivity analysis including
imputed preadmission creatinine values, in which we found an overall 30-day AKI risk of
27%. The cumulative 30-day risks of AKI were 24%, 26%, 35%, 44%, and 49% for patients with
eGFR�90, 60–89, 45–59, 30–44 and>30, respectively. In this analysis, we found similar asso-
ciations between kidney function and AKI, but ORs are slightly higher compared with the pri-
mary analysis only including complete cases (S2 Table). A total of 89.3% of the AKI cases (i.e.
1,882 cases) occurred in the first week from the day of hospital admission. We found a similar
association between kidney function and AKI in the sensitivity analysis of AKI within 7 days
after admission, but ORs were slightly lower compared with the primary analysis (S3 Table).
In the subgroup analysis stratified by sex, the ORs were comparable with the ORs from the
main analysis without firm evidence of interaction (p = 0.07) (S4 Table). The association
between preadmission eGFR and AKI attenuated slightly after adjustment for obstructive
nephropathy (S5 Table).
Fig 2. The cumulative 30-day risk of acute kidney injury after admission with pyelonephritis by different preadmission
eGFR categories. Abbreviations: eGFR, estimated glomerular filtration rate.
https://doi.org/10.1371/journal.pone.0247687.g002
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Discussion
Key findings
In this large population-based cohort study including nearly 9,000 patients with a first-time
diagnosis of acute pyelonephritis, we found that the overall 30-day risk of AKI was 24% for
patients with at least one preadmission creatinine measurement. This 30-day risk of AKI
increased in a dose-response relationship with lower preadmission eGFR category and was
47% for patients with eGFR<30ml/min/1.73m2, and was not explained by the included con-
founding variables.
Strengths and limitations
This is a large population-based study of pyelonephritis-related AKI, using laboratory infor-
mation on pre- and post-admission creatinine. Even though the laboratory information was
not complete, using laboratory data to identify reduced preadmission eGFR is known to be
more accurate than using diagnostic codes, and similarly using creatinine measurements will
capture more accurately incident cases of AKI [5, 7, 10, 42–44]. The study has some limitations
that should be considered when interpreting the findings. First, we identified our study cohort
using the nationwide Danish National Patient Registry including all patients hospitalized and
diagnosed with acute pyelonephritis [20]. Still, selection bias may have occurred as we
restricted our main analysis to patients with measurements of serum creatinine both before
and after admission which means that those included in the complete case analysis are sicker/
older than those excluded [23]. Multiple imputation of missing values did not change our find-
ings, which was reassuring. Second, the regional LABKA database was fairly complete from
2000 and onwards and The Register of Laboratory Results for Research included an increasing
number of hospital throughout the study period [18, 21]. However, we do not expect incom-
pleteness to bias our findings because the incompleteness of The Register of Laboratory Results
Fig 3. Forest plot: Events of acute kidney injury within 30 days after pyelonephritis admission/total, and odds ratios from sex/age adjusted and fully
adjusted logistic regression analyses by different preadmission eGFR categories. Abbreviations: ORs, odds ratios; eGFR, estimated glomerular filtration rate.
Fully adjusted: adjusted for age, sex, diabetes, hypertension, heart failure, and malformation of the urinary tract.
https://doi.org/10.1371/journal.pone.0247687.g003
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for Research was presumed to be independent of both preadmission kidney function and the
risk of AKI. Third, to avoid misclassification of exposure status, we excluded patients without
any serum creatinine measurement in the year to seven days prior to admission in the main
analyses. These could be patients who were not covered by the laboratory databases, but since
patients with missing information on preadmission creatinine were overall much younger and
had low comorbidity, it might indicate that most of them were excluded because they simply
have not had any creatinine measurements one year prior to admission. Data from the UK
suggest that people without any creatinine measurement are very likely to have predominately
eGFR>60 ml/min/1.73 m2, so most of these would have contributed to the denominator popu-
lations at the higher range of eGFR and reduced the AKI incidence seen for the higher eGFR
range–as a result the impact of reduced eGFR on incidence of AKI is probably much more
pronounced than estimated by us in this conservative analysis [45]. Fourth, although we
included several potential confounders in the analyses, we cannot entirely rule out any unmea-
sured or residual confounding [29]. Because all our data are from secondary data collection,
we lacked information on lifestyle factors, which could have been potential confounders such
as body mass index or smoking, though adjustment for comorbid status will have captured the
Fig 4. Graph of the cubic spline model relating exact estimated glomerular filtration rate (eGFR) to the fully adjusted odds ratios (95% CI) of acute
kidney injury within 30 days after admission with pyelonephritis. Abbreviations: eGFR, estimated glomerular filtration rate. Adjusted for age, sex, diabetes,
hypertension, heart failure, and malformation of the urinary tract. Preadmission eGFR is calculated most the most recent outpatients creatinine measurement
one year to seven days before pyelonephritis admission.
https://doi.org/10.1371/journal.pone.0247687.g004
PLOS ONE Risk of acute kidney injury by preadmission kidney function in pyelonephritis patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0247687 March 3, 2021 9 / 14
impact of prolonged poor lifestyle factors. We also lacked information on ethnicity. Approx.
9% of the population have a non-Western background and therefore we cannot exclude any
minor bias when assuming that all patients are Caucasian [46]. However, since the majority of
the Danish population is Caucasian, this was not expected to influence our results substantially
[11, 34].
Interpretation
Our finding of a 30-day risk of AKI ranging between 16% and 47% depending on preadmis-
sion kidney function is consistent with the overall risk of AKI among all hospitalizations
found in a meta-analysis by Susantitaphong et al. [4]. However, as is usual in clinical practice
all over the world, tests for kidney function are not routinely done in everybody, and data
from this meta-analysis are affected by the same limitations as discussed above. Interestingly,
we found a U-shaped association between exact eGFR value and the 30-day risk of AKI, but
this could in parts be driven by regression to the mean. Results from patients with eGFR�90
ml/min/1.73 m2 should therefore be interpreted with caution because the CKD-EPI formula is
very imprecise at that level of kidney function [26].
Most AKI cases (89.3%) within the 30 days after hospitalization occurred within the first 7
days, which underscores the immediate risk of AKI after hospitalization with pyelonephritis.
Complications to pyelonephritis, antibiotic treatment, or underlying disease may contribute to
the AKI cases occurring later during the hospitalization.
We found slightly lower ORs when adjusting for obstructive nephropathy (S5 Table). This
indicates that some of the found association between preadmission eGFR and AKI could be
explained by obstructive nephropathy, but the association persists even after adjustment for
this covariate.
Only few smaller studies with a maximum of 790 participants have evaluated the association
between impaired kidney function and AKI among patients with pyelonephritis or urinary
tract infections [5, 6]. In a smaller study including 403 pyelonephritis patients, Jeon et al.
reported an AKI risk as high as 62.8% [5]. We did not find that high risk of AKI, not even
among patients with eGFR < 30 ml/min/1.73 m2. This could be due to the fact that they have
used single-imputation methods assuming eGFR 75 ml/min/1.73 m2 when preadmission cre-
atinine was missing whereas we have done a complete case analysis. To the best of our knowl-
edge, only one smaller study has evaluated the association between impaired kidney function
and AKI with preadmission eGFR categorized into more than two groups [6]. Even though
that study also included patients with lower urinary tract infection, they similarly found a
dose-response relationship between preadmission eGFR and AKI. Our study thereby extends
these previous findings potentially pointing towards a causal association.
The findings of this study suggest that preadmission impaired kidney function is an impor-
tant risk factor for development of AKI in hospitalized patients with pyelonephritis. Our find-
ings confirm an association between chronic kidney impairment and AKI in patients with
pyelonephritis that could not be explained by measured confounding. These findings add one
more reason why more attention should be raised in prevention of pyelonephritis associated
AKI, perhaps by addressing structural problems, or considering prophylactic treatment or
immediate treatment of urinary tract infections with medication stored at home for those with
recurrent urinary tract infections, to prevent further worsening of kidney function. This is
important because AKI increases the risk of subsequent progression of chronic kidney disease
[11]. Therefore, chronic kidney disease patients are a high-risk patient group and more atten-
tion should be raised at prevention and treatment of pyelonephritis among these patients.
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